Quoin Pharmaceuticals Appoints Gordon Dunn as Chief Financial Officer
04 nov. 2021 09h25 HE
|
Quoin Pharmaceuticals, Inc.
ASHBURN, Va., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today...
Quoin Pharmaceuticals Announces Signing of Exclusive License from Queensland University of Technology, Australia
02 nov. 2021 08h30 HE
|
Quoin Pharmaceuticals, Inc.
ASHBURN, Va., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today...